Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Aroa Biosurgery Ltd ( (AU:ARX) ) is now available.
Aroa Biosurgery Ltd announced the cessation of several securities due to unmet conditions, affecting options and performance share rights. This development may impact the company’s financial strategies and stakeholder interests, as it reflects a reevaluation of certain financial instruments within the organization.
The most recent analyst rating on (AU:ARX) stock is a Buy with a A$0.93 price target. To see the full list of analyst forecasts on Aroa Biosurgery Ltd stock, see the AU:ARX Stock Forecast page.
More about Aroa Biosurgery Ltd
Aroa Biosurgery Ltd operates in the medical technology industry, focusing on the development and commercialization of regenerative tissue products. The company provides innovative solutions for soft tissue repair and reconstruction, catering primarily to the healthcare sector.
Average Trading Volume: 269,731
Technical Sentiment Signal: Buy
Current Market Cap: A$198.4M
See more insights into ARX stock on TipRanks’ Stock Analysis page.